The U.S. Anti-Doping Agency (USADA) has released a statement on Lyman Good’s six-month suspension.
This past weekend, Good’s lawyer David Fish confirmed that his fighter had accepted the suspension retroactive to Oct. 24, 2016. Good had failed an out-of-competition drug test. He hasn’t competed since July 2015.
You can read part of USADA’s statement below:
“Good, 32, tested positive for 1-androstenedione and its metabolite 1-(5α)-androsten-3α-ol-17-one following an out-of-competition test conducted on October 14, 2016. 1-androstenedione is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List. Following notification of his positive test, Good provided USADA with information about a dietary supplement product he was using at the time of the relevant sample collection. Although no prohibited substances were listed on the supplement label, testing conducted on an independently sourced, unopened container of the product by the WADA-accredited laboratory in Salt Lake City, Utah, indicated that it contained 1-androstenedione. The presence of an undisclosed prohibited substance in a product is regarded as contamination. Accordingly, the product has since been added to the High Risk List of supplements maintained on USADA’s online dietary supplement safety education and awareness resource.”
